scholarly journals Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer

2005 ◽  
Vol 117 (6) ◽  
pp. 974-980 ◽  
Author(s):  
Ji-Ching Lai ◽  
Ya-Wen Cheng ◽  
Hui-Ling Chiou ◽  
Ming-Fang Wu ◽  
Chin-Yi Chen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Estrogen Receptor ◽  
Gender Difference ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Estrogen Receptor Alpha ◽  
Promoter Hypermethylation ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals PUB064 Correlation between Estrogen Receptor Alpha and Beta and the Markers Coexpression in Non-Small Cell Lung Cancer (NSCLC) Tissue

2017 ◽  
Vol 12 (1) ◽  
pp. S1485
Author(s):  
Evgeniya Ponomarenko ◽  
Evgeny Dudko ◽  
Tatiana Bogush ◽  
Dmitriy Novikov ◽  
Olga Rjabinina ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Estrogen Receptor ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Estrogen Receptor Alpha ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Receptor Alpha

scholarly journals Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women

2010 ◽  
Vol 31 (10) ◽  
pp. 1778-1786 ◽  
Author(s):  
Susan E. Olivo-Marston ◽  
Leah E. Mechanic ◽  
Steen Mollerup ◽  
Elise D. Bowman ◽  
Alan T. Remaley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Estrogen Receptor ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Estrogen Receptor Alpha ◽  
Cancer Survival ◽  
Small Cell ◽  
Small Cell Lung ◽  
Men And Women ◽  
Lung Cancer Survival

The prognostic value of residual mediastinal involvement following induction therapy and surgery for locally advanced non-small cell lung cancer

Lung Cancer ◽  
2004 ◽  
Vol 46 (1) ◽  
pp. 125-126
Author(s):  
Stefano Margaritora ◽  
Alfredo Cesario ◽  
Domenico Galetta ◽  
Venanzio Porziella ◽  
Silvia Sterzi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Induction Therapy ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Mediastinal Involvement

scholarly journals Comprehensive analysis of prognostic value and immune infiltration of kindlin family members in non-small cell lung cancer

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Xiaoshan Su ◽  
Ning Liu ◽  
Weijing Wu ◽  
Zhixing Zhu ◽  
Yuan Xu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Small Cell Lung Cancer ◽  
Cell Lines ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Small Cell ◽  
Nsclc Cell ◽  
Small Cell Lung ◽  
Immune Infiltration

Abstract Background Kindlin Family Members have been reported to be aberrantly expressed in various human cancer types and involved in tumorigenesis, tumor progression, and chemoresistance. However, their roles in non-small cell lung cancer (NSCLC) remain poorly elucidated. Methods We analyzed the prognostic value and immune infiltration of Kindlins in NSCLC through Oncomine, GEPIA, UALCAN, CCLE, Kaplan‑Meier plotter, cBioPortal, TIMER, GeneMANIA, STRING, and DAVID database. Additionally, the mRNA expression levels of Kindlins were verified in 30 paired NSCLC tissues and NSCLC cell lines by real-time PCR. Results The expression level of FERMT1 was remarkably increased in NSCLC tissues and NSCLC cell lines, while FERMT2 and FERMT3 were reduced. Kindlins expressions were associated with individual cancer stages and nodal metastasis. We also found that higher expression level of FERMT1 was obviously correlated with worse overall survival (OS) in patients with NSCLC, while higher FERMT2 was strongly associated with better overall survival (OS) and first progression (FP). Additionally, the expression of FERMT2 and FERMT3 were obviously correlated with the immune infiltration of diverse immune cells. Functional enrichment analysis has shown that Kindlins may be significantly correlated with intracellular signal transduction, ATP binding and the PI3K-Akt signaling pathway in NSCLC. Conclusions The research provides a new perspective on the distinct roles of Kindlins in NSCLC and likely has important implications for future novel biomarkers and therapeutic targets in NSCLC.

Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancer

Biomarkers ◽  
2006 ◽  
Vol 11 (3) ◽  
pp. 262-269 ◽  
Author(s):  
E. Jassem ◽  
K. Serkies ◽  
R. Dziadziuszko ◽  
A. Drozdowska ◽  
G. Kobierska-Gulida ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Small Cell ◽  
Tumour Cells ◽  
Small Cell Lung ◽  
S 100

Corrigendum to “Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter” [Lung Cancer 46 (2004) 325–331]

Lung Cancer ◽  
2005 ◽  
Vol 50 (2) ◽  
pp. 281-282
Author(s):  
Ayten Kayi Cangir ◽  
Hakan Kutlay ◽  
Murat Akal ◽  
Adem Güngör ◽  
Nezih Özdemir ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Size ◽  
Prognostic Value ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document